Icon
+91 94997 68112
Login Register

Bromsite - (0.075%; Solution/Drops, Ophthalmic)

Bromfenac Sodium Sun Pharma
0.075%; Solution/Drops, Ophthalmic
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
Yes
***** ** *** ***** ** **** **** ** **** ****** '*** ******** ** **** *, ****. ** ****** **** **** ***** ******* ** *** ****. *** ***** ** *** ******* ** *** ********* *** ** ****** ** ** ** **** ***.
Bromsite Patent 1
***** *** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **, **** *** ** ** ******** ******** ** *** **, ****
  1. *** *, **** : ***** ******** *** ***** *** **** ** **** ****** '*** (**** *, ****).
  2. *** **, **** : *** ****** ***** * **** ******* ***** ** ******** ***** ** **.
  3. *** **, **** : ***** *** ** ** ** *** ***** ***** *****'* **** ***-**********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.